Skip to content
Screener

Sanara MedTech Inc. SMTI Q1 2025 earnings

Reported May 14, 2025 · Before market open

Revenue$23.4MMiss by $1.5M
EPS-$0.41Miss by $0.10
Revenue estimate$24.9M
EPS estimate-$0.31

Next report

Nov 11, 2026 (in a month)
Revenue estimate$29.7M
EPS estimate$0.06

Financials

Q1 2025

Income statement

See full
Revenue$23.4M+26.4%
Gross profit$21.6M+29.8%
Operating income$825.5K+154%
Net income-$3.5M-99.9%
EPS (diluted)-$0.41-95.2%

Balance sheet

See full
Cash & equivalents$20.7M+631%
Total debt$44.7M+282%
Total equity$36.7M-15.3%
Total assets$96.4M+35.9%

Cash flow

See full
Operating cash flow-$2.0M-25.4%
CapEx$1.7M+2,517%
Free cash flow-$3.7M-124%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$274.8M-13.0%
Enterprise value$298.83M-8.0%
P/S3×-1.6×

Profitability

See full
Gross margin91.2%+2.4pp
Operating margin1.1%+0.6pp
Net margin-12.5%+34.7pp

Returns & leverage

See full
Return on equity-28.6%-87.9pp
Debt / equity1.2×+0.9×
Current ratio2.8×+1.4×

Segments

By product

See full
Soft Tissue Repair Products$20.5M+27.7%
Bone Fusion Products$2.9M+18.2%

FAQ

When did Sanara MedTech Inc. report Q1 2025 earnings?
Sanara MedTech Inc. (SMTI) reported Q1 2025 earnings on May 14, 2025 before market open.
What were Sanara MedTech Inc.'s Q1 2025 revenue and EPS?
Sanara MedTech Inc. reported revenue of $23.4M and eps of $-0.41 for Q1 2025.
Did Sanara MedTech Inc. beat estimates in Q1 2025?
Revenue missed the consensus estimate of $24.9M by $1.5M. EPS missed the consensus estimate of $-0.31 by $0.10.
How did Sanara MedTech Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 26.4% from $18.5M a year earlier and eps declined 95.2% from $-0.21.
Where can I find Sanara MedTech Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001641172-25-010097) and the 10-Q periodic report (0001641172-25-010254) directly on SEC EDGAR. The filing index links above go to sec.gov.